Review: Endocrine disrupting chemicals and immune responses: A focus on bisphenol-A and its potential mechanisms

Molecular Immunology

Volumn 53, Issue 4, 2013, Pages 421-430

  Rogers, James A ^a   Metz, Luanne ^a   Yong, V Wee ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Autoimmunity; Inflammation; Lymphocytes; Macrophages; PPAR

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; AROMATIC HYDROCARBON RECEPTOR; CD4 ANTIGEN; ENDOCRINE DISRUPTOR; ESTROGEN RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

B LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHEMICAL STRUCTURE; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

ANIMALS; B-LYMPHOCYTES; BENZHYDRYL COMPOUNDS; DENDRITIC CELLS; ENDOCRINE DISRUPTORS; ENDOCRINE SYSTEM; GENE EXPRESSION; HUMANS; MACROPHAGES; MICE; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PHENOLS; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS;

EID: 84868258039     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2012.09.013     Document Type: Review

References (111)

1. Ballesteros-Gomez A., Ruiz F.J., Rubio S., Perez-Bendito D. Determination of bisphenols A and F and their diglycidyl ethers in wastewater and river water by coacervative extraction and liquid chromatography-fluorimetry. Analytica Chimica Acta 2007, 603:51-59.
2. Bebo B.F., Fyfe-Johnson A., Adlard K., Beam A.G., Vandenbark A.A., Offner H. Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. Journal of Immunology 2001, 166:2080-2089.
3. Belfroid A., van Velzen M., van der Horst B., Vethaak D. Occurrence of bisphenol A in surface water and uptake in fish: evaluation of field measurements. Chemosphere 2002, 49:97-103.
4. Bianco J.J., McPherson S.J., Wang H., Prins G.S., Risbridger G.P. Transient neonatal estrogen exposure to estrogen-deficient mice (aromatase knockout) reduces prostate weight and induces inflammation in late life. The American Journal of Pathology 2006, 168:1869-1878.
5. Birnbaum L.S., Fenton S.E. Cancer and developmental exposure to endocrine disruptors. Environmental Health Perspectives 2003, 111:389-394.
6. Bolli A., Bulzomi P., Galluzzo P., Acconcia F., Marino M. Bisphenol A impairs estradiol-induced protective effects against DLD-1 colon cancer cell growth. IUBMB Life 2010, 62:684-687.
7. Bommhardt U., Beyer M., Hunig T., Reichardt H.M. Molecular and cellular mechanisms of T cell development. Cellular and Molecular Life Sciences (CMLS) 2004, 61:263-280.
8. Bonefeld-Jorgensen E.C., Long M., Hofmeister M.V., Vinggaard A.M. Endocrine-disrupting potential of bisphenol A, bisphenol A dimethacrylate, 4-n-nonylphenol, and 4-n-octylphenol in vitro: new data and a brief review. Environmental Health Perspectives 2007, 115(Suppl. 1):69-76.
9. Bynote K.K., Hackenberg J.M., Korach K.S., Lubahn D.B., Lane P.H., Gould K.A. Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZB x NZW) F1 mice. Genes and Immunity 2008, 9:137-152.
10. Byun J.A., Heo Y., Kim Y.O., Pyo M.Y. Bisphenol A-induced downregulation of murine macrophage activities in vitro and ex vivo. Environmental Toxicology and Pharmacology 2005, 19:19-24.
11. Cariou R., Antignac J.P., Zalko D., Berrebi A., Cravedi J.P., Maume D., Marchand P., Monteau F., Riu A., Andre F., Le Bizec B. Exposure assessment of French women and their newborns to tetrabromobisphenol-A: occurrence measurements in maternal adipose tissue, serum, breast milk and cord serum. Chemosphere 2008, 73:1036-1041.
12. Chandra V., Huang P., Hamuro Y., Raghuram S., Wang Y., Burris T.P., Rastinejad F. Structure of the intact PPAR-γ-RXR-α nuclear receptor complex on DNA. Nature 2008, 350-356.
13. Chao T.C., Van Alten P.J., Greager J.A., Walter R.J. Steroid sex hormones regulate the release of tumor necrosis factor by macrophages. Cellular Immunology 1995, 160:43-49.
14. Chinetti G., Griglio S., Antonucci M., Torra I.P., Delerive P., Majd Z., Fruchart J.C., Chapman J., Najib J., Staels B. Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. The Journal of Biological Chemistry 1998, 273:25573-25580.
15. Cooper J.E., Kendig E.L., Belcher S.M. Assessment of bisphenol A released from reusable plastic, aluminium and stainless steel water bottles. Chemosphere 2011, 85:943-947.
16. Crain D.A., Eriksen M., Iguchi T., Jobling S., Laufer H., LeBlanc G.A., Guillette L.J. An ecological assessment of bisphenol-A: evidence from comparative biology. Reproductive Toxicology 2007, 24:225-239.
17. Crispin J.C., Liossis S.N., Kis-Toth K., Lieberman L.A., Kyttaris V.C., Juang Y.T., Tsokos G.C. Pathogenesis of human systemic lupus erythematosus: recent advances. Trends in Molecular Medicine 2010, 16:47-57.
18. Cunningham M., Gilkeson G. Estrogen receptors in immunity and autoimmunity. Clinical Reviews in Allergy and Immunology 2011, 40:66-73.
19. Curras-Collazo M.C. Nitric oxide signaling as a common target of organohalogens and other neuroendocrine disruptors. Journal of Toxicology and Environmental Health. Part B: Critical Reviews 2011, 14:495-536.
20. Doherty L.F., Bromer J.G., Zhou Y., Aldad T.S., Taylor H.S. In utero exposure to diethylstilbestrol (DES) or bisphenol-A (BPA) increases EZH2 expression in the mammary gland: an epigenetic mechanism linking endocrine disruptors to breast cancer. Hormones and Cancer 2010, 1:146-155.
21. Elango A., Shepherd B., Chen T.T. Effects of endocrine disrupters on the expression of growth hormone and prolactin mRNA in the rainbow trout pituitary. General and Comparative Endocrinology 2006, 145:116-127.
22. Frericks M., Meissner M., Esser C. Microarray analysis of the AHR system: tissue-specific flexibility in signal and target genes. Toxicology and Applied Pharmacology 2007, 220:320-332.
23. Gerriets V.A., Rathmell J.C. Metabolic pathways in T cell fate and function. Trends in Immunology 2012, 33:168-173.
24. Glass C.K., Saijo K. Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nature Reviews. Immunology 2010, 10:365-376.
25. Gori I., Pellegrini C., Staedler D., Russell R., Jan C., Canny G.O. Tumor necrosis factor-alpha activates estrogen signaling pathways in endometrial epithelial cells via estrogen receptor alpha. Molecular and Cellular Endocrinology 2011, 345:27-37.
26. Gosset P., Charbonnier A.S., Delerive P., Fontaine J., Staels B., Pestel J., Tonnel A.B., Trottein F. Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells. European Journal of Immunology 2001, 31:2857-2865.
27. Goto M., Ono H., Takano-Ishikawa Y., Shinmoto H., Yoshida M. Mac1 positive cells are required for enhancement of splenocytes proliferation caused by bisphenol a. Bioscience, Biotechnology, and Biochemistry 2004, 68:263-265.
28. Goto M., Takano-Ishikawa Y., Ono H., Yoshida M., Yamaki K., Shinmoto H. Orally administered bisphenol A disturbed antigen specific immunoresponses in the naive condition. Bioscience, Biotechnology, and Biochemistry 2007, 71:2136-2143.
29. Grumetto L., Montesano D., Seccia S., Albrizio S., Barbato F. Determination of bisphenol A and bisphenol B residues in canned peeled tomatoes by reversed-phase liquid chromatography. Journal of Agricultural and Food Chemistry 2008, 56:10633-10637.
30. Guo H., Liu T., Uemura Y., Jiao S., Wang D., Lin Z., Narita Y., Suzuki M., Hirosawa N., Ichihara Y., Ishihara O., Kikuchi H., Sakamoto Y., Senju S., Zhang Q., Ling F. Bisphenol A in combination with TNF-alpha selectively induces Th2 cell-promoting dendritic cells in vitro with an estrogen-like activity. Cellular and Molecular Immunology 2010, 7:227-234.
31. Guo X., Tang Y. OCT4 pseudogenes present in human leukemia cells 2011, Clinical and experimental medicine.
32. Hisahiko Hiroi O.T., Momoeda M., Takai Y., Ousaga Y., Taketani Y. Differential interactions of bisphenol-A and 17B-estradiol with estrogen receptor a (ERa) and ERb. Endocrine Journal 1999, 46:773-778.
33. Hong C.C., Shimomura-Shimizu M., Muroi M., Tanamoto K. Effect of endocrine disrupting chemicals on lipopolysaccharide-induced tumor necrosis factor-alpha and nitric oxide production by mouse macrophages. Biological and Pharmaceutical Bulletin 2004, 27:1136-1139.
34. Ikezuki Y., Tsutsumi O., Takai Y., Kamei Y., Taketani Y. Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Human Reproduction 2002, 17:2839-2841.
35. Jones D.C., Ding X.H., Daynes R.A. Nuclear receptor peroxisome proliferator-activated receptor a (PPAR alpha) is expressed in resting murine lymphocytes - the PPAR alpha in T and B lymphocytes is both transactivation and transrepression competent. Journal of Biological Chemistry 2002, 277:6838-6845.
36. Jung E.M., Choi K.C., Yu F.H., Jeung E.B. Effects of 17beta-estradiol and xenoestrogens on mouse embryonic stem cells. Toxicology In Vitro: An International Journal Published in Association with BIBRA 2010, 24:1538-1545.
37. Kavlock R.J., Daston G.R., DeRosa C., Fenner-Crisp P., Earl Gray L., Kaattari S., Lucier G., Luster M., Mac M.J., Maczka C., Miller R., Moore J., Roland R., Scott G., Sheehan D.M., Sinks T., Tilson H.A. Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. Environmental Health Perspectives 1996, 104:715-740.
38. Kim J.Y., Jeong H.G. Down-regulation of inducible nitric oxide synthase and tumor necrosis factor-alpha expression by bisphenol A via nuclear factor-kappaB inactivation in macrophages. Cancer Letters 2003, 196:69-76.
39. Klecka G.M., Staples C.A., Clark K.E., Van der Hoeven N., Thomas D.E., Hentges S.G. Exposure analysis of bisphenol A in surface water systems in North America and Europe. Environmental Science and Technology 2009, 43:6145-6150.
40. Ko G.J., Kang Y.S., Han S.Y., Lee M.H., Song H.K., Han K.H., Kim H.K., Han J.Y., Cha D.R. Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association, European Renal Association 2008, 23:2750-2760.
41. Korn-Lubetzki I., Kahana E., Cooper G., Abramsky O. Activity of multiple sclerosis during pregnancy and puerperium. Annals of Neurology 1984, 16:229-231.
42. Krishnan A.V., Stathis P., Permuth S.F., Tokes L., Feldman D. Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 1993, 132:2279-2286.
43. Kruger T., Long M., Bonefeld-Jorgensen E.C. Plastic components affect the activation of the aryl hydrocarbon and the androgen receptor. Toxicology 2008, 246:112-123.
44. Kuan Y.H., Li Y.C., Huang F.M., Chang Y.C. The upregulation of tumour necrosis factor-alpha and surface antigens expression on macrophages by bisphenol A-glycidyl-methacrylate. International Endodontic Journal 2012, 45:619-626.
45. Kubwabo C., Kosarac I., Stewart B., Gauthier B.R., Lalonde K., Lalonde P.J. Migration of bisphenol A from plastic baby bottles, baby bottle liners and reusable polycarbonate drinking bottles. Food Additives and Contaminants. Part A: Chemistry, Analysis, Control, Exposure and Risk Assessment 2009, 26:928-937.
46. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der Burg B., Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139:4252-4263.
47. Lawrence B.P., Denison M.S., Novak H., Vorderstrasse B.A., Harrer N., Neruda W., Reichel C., Woisetschlager M. Activation of the aryl hydrocarbon receptor is essential for mediating the anti-inflammatory effects of a novel low-molecular-weight compound. Blood 2008, 112:1158-1165.
48. le Maire A., Grimaldi M., Roecklin D., Dagnino S., Vivat-Hannah V., Balaguer P., Bourguet W. Activation of RXR-PPAR heterodimers by organotin environmental endocrine disruptors. EMBO Reports 2009, 10:367-373.
49. Lee J., Lim K.T. Plant-originated glycoprotein (36kDa) suppresses interleukin-4 and -10 in bisphenol A-stimulated primary cultured mouse lymphocytes. Drug and Chemical Toxicology 2010, 33:421-429.
50. Lee M.H., Chung S.W., Kang B.Y., Park J., Lee C.H., Hwang S.Y., Kim T.S. Enhanced interleukin-4 production in CD4+ T cells and elevated immunoglobulin E levels in antigen-primed mice by bisphenol A and nonylphenol, endocrine disruptors: involvement of nuclear factor-AT and Ca2+. Immunology 2003, 109:76-86.
51. Levy G. Bisphenol A induces feminization in Xenopus laevis tadpoles. Environmental Research 2004, 94:102-111.
52. Liu Y., Shi J., Lu J., Meng G., Zhu H., Hou Y., Yin Y., Zhao S., Ding B. Activation of peroxisome proliferator-activated receptor-gamma potentiates pro-inflammatory cytokine production, and adrenal and somatotropic changes of weaned pigs after Escherichia coli lipopolysaccharide challenge. Innate Immunity 2009, 15:169-178.
53. Maffini M.V., Rubin B.S., Sonnenschein C., Soto A.M. Endocrine disruptors and reproductive health: the case of bisphenol-A. Molecular and Cellular Endocrinology 2006, 254-255:179-186.
54. Manabe I. Chronic inflammation links cardiovascular, metabolic and renal diseases. Circulation Journal 2011, 75:2739-2748.
55. Maret A., Coudert J.D., Garidou L., Foucras G., Gourdy P., Krust A., Dupont S., Chambon P., Druet P., Bayard F., Guery J.C. Estradiol enhances primary antigen-specific CD4T cell responses and Th1 development in vivo. Essential role of estrogen receptor alpha expression in hematopoietic cells. European Journal of Immunology 2003, 33:512-521.
56. Meng Q.Q., Liang X.J., Wang P., Wang X.P., Yang J.W., Wu Y.F., Shen H.Y. Rosiglitazone enhances the proliferation of neural progenitor cells and inhibits inflammation response after spinal cord injury. Neuroscience Letters 2011, 503:191-195.
57. Miao S., Gao Z., Kou Z., Xu G., Su C., Liu N. Influence of bisphenol a on developing rat estrogen receptors and some cytokines in rats: a two-generational study. Journal of Toxicology and Environmental Health A 2008, 71:1000-1008.
58. Midoro-Horiuti T., Tiwari R., Watson C.S., Goldblum R.M. Maternal bisphenol a exposure promotes the development of experimental asthma in mouse pups. Environmental Health Perspectives 2010, 118:273-277.
59. Mor G., Sapi E., Abrahams V.M., Rutherford T., Song J., Hao X.Y., Muzaffar S., Kohen F. Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes. Journal of Immunology 2003, 170:114-122.
60. Moriyama K., Tagami T., Akamizu T., Usui T., Saijo M., Kanamoto N., Hataya Y., Shimatsu A., Kuzuya H., Nakao K. Thyroid hormone action is disrupted by bisphenol A as an antagonist. The Journal of Clinical Endocrinology and Metabolism 2002, 87:5185-5190.
61. Murray T.J., Maffini M.V., Ucci A.A., Sonnenschein C., Soto A.M. Induction of mammary gland ductal hyperplasias and carcinoma in situ following fetal bisphenol A exposure. Reproductive Toxicology 2007, 23:383-390.
62. Nakamura K., Kariyazono H. Influence of endocrine-disrupting chemicals on the immune system. Journal of Health Science 2010, 56:361-373.
63. Nalbandian G., Kovats S. Understanding sex biases in immunity: effects of estrogen on the differentiation and function of antigen-presenting cells. Immunologic Research 2005, 31:91-106.
64. Niino M., Iwabuchi K., Kikuchi S., Ato M., Morohashi T., Ogata A., Tashiro K., Onoe K. Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-gamma. Journal of Neuroimmunology 2001, 116:40-48.
65. Ohshima Y., Yamada A., Tokuriki S., Yasutomi M., Omata N., Mayumi M. Transmaternal exposure to bisphenol a modulates the development of oral tolerance. Pediatric Research 2007, 62:60-64.
66. Panchanathan R., Shen H., Zhang X., Ho S.M., Choubey D. Mutually positive regulatory feedback loop between interferons and estrogen receptor-alpha in mice: implications for sex bias in autoimmunity. PLoS One 2010, 5:e10868.
67. Petri M., Howard D., Repke J. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis and Rheumatism 1991, 34:1538-1545.
68. Phiel K.L., Henderson R.A., Adelman S.J., Elloso M.M. Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations. Immunology Letters 2005, 97:107-113.
69. Pocar P., Fischer B., Klonisch T., Hombach-Klonisch S. Molecular interactions of the aryl hydrocarbon receptor and its biological and toxicological relevance for reproduction. Reproduction 2005, 129:379-389.
70. Polak P.E., Kalinin S., Dello Russo C., Gavrilyuk V., Sharp A., Peters J.M., Richardson J., Willson T.M., Weinberg G., Feinstein D.L. Protective effects of a peroxisome proliferator-activated receptor-beta/delta agonist in experimental autoimmune encephalomyelitis. Journal of Neuroimmunology 2005, 168:65-75.
71. Qin X.Y., Zaha H., Nagano R., Yoshinaga J., Yonemoto J., Sone H. Xenoestrogens down-regulate aryl-hydrocarbon receptor nuclear translocator 2 mRNA expression in human breast cancer cells via an estrogen receptor alpha-dependent mechanism. Toxicology Letters 2011, 206:152-157.
72. Quintana F.J., Basso A.S., Iglesias A.H., Korn T., Farez M.F., Bettelli E., Caccamo M., Oukka M., Weiner H.L. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008, 453:65-71.
73. Raikwar H.P., Muthian G., Rajasingh J., Johnson C., Bright J.J. PPARgamma antagonists exacerbate neural antigen-specific Th1 response and experimental allergic encephalomyelitis. Journal of Neuroimmunology 2005, 167:99-107.
74. Riu A., Grimaldi M., le Maire A., Bey G., Phillips K., Boulahtouf A., Perdu E., Zalko D., Bourguet W., Balaguer P. Peroxisome proliferator-activated receptor gamma is a target for halogenated analogs of bisphenol A. Environmental Health Perspectives 2011, 119:1227-1232.
75. Rubin B.S. Bisphenol A: an endocrine disruptor with widespread exposure and multiple effects. The Journal of Steroid Biochemistry and Molecular Biology 2011, 127:27-34.
76. Rubin B.S., Soto A.M. Bisphenol A: perinatal exposure and body weight. Molecular and Cellular Endocrinology 2009, 304:55-62.
77. Rubtsov A.V., Rubtsova K., Kappler J.W., Marrack P. Genetic and hormonal factors in female-biased autoimmunity. Autoimmunity Reviews 2010, 9:494-498.
78. Salazar K.D., Miller M.R., Barnett J.B., Schafer R. Evidence for a novel endocrine disruptor: the pesticide propanil requires the ovaries and steroid synthesis to enhance humoral immunity. Toxicological Sciences: An Official Journal of the Society of Toxicology 2006, 93:62-74.
79. Sawai C., Anderson K., Walser-Kuntz D. Effect of bisphenol A on murine immune function: modulation of interferon-gamma, IgG2a, and disease symptoms in NZB X NZW F1 mice. Environmental Health Perspectives 2003, 111:1883-1887.
80. Schug T.T., Janesick A., Blumberg B., Heindel J.J. Endocrine disrupting chemicals and disease susceptibility. The Journal of Steroid Biochemistry and Molecular Biology 2011, 127:204-215.
81. Segura J.J., Jimenez-Rubio A., Pulgar R., Olea N., Guerrero J.M., Calvo J.R. In vitro effect of the resin component bisphenol A on substrate adherence capacity of macrophages. Journal of Endodontics 1999, 25:341-344.
82. Sellin M.K., Snow D.D., Schwarz M., Carter B.J., Kolok A.S. Agrichemicals in Nebraska, USA, watersheds: occurrence and endocrine effects. Environmental Toxicology and Chemistry/SETAC 2009, 28:2443-2448.
83. Setoguchi K., Misaki Y., Terauchi Y., Yamauchi T., Kawahata K., Kadowaki T., Yamamoto K. Peroxisome proliferator-activated receptor-gamma haploinsufficiency enhances B cell proliferative responses and exacerbates experimentally induced arthritis. The Journal of Clinical Investigation 2001, 108:1667-1675.
84. Siracusa M.C., Overstreet M.G., Housseau F., Scott A.L., Klein S.L. 17beta-estradiol alters the activity of conventional and IFN-producing killer dendritic cells. Journal of Immunology 2008, 180:1423-1431.
85. Soto A.M., Sonnenschein C. Environmental causes of cancer: endocrine disruptors as carcinogens. Nature Reviews. Endocrinology 2010, 6:363-370.
86. Staels B., Fruchart J.C. Therapeutic roles of peroxisome proliferator-activated receptor agonists. Diabetes 2005, 54:2460-2470.
87. Stockinger B., Hirota K., Duarte J., Veldhoen M. External influences on the immune system via activation of the aryl hydrocarbon receptor. Seminars in Immunology 2011, 23:99-105.
88. Sun C., Leong L.P., Barlow P.J., Chan S.H., Bloodworth B.C. Single laboratory validation of a method for the determination of Bisphenol A, Bisphenol A diglycidyl ether and its derivatives in canned foods by reversed-phase liquid chromatography. Journal of Chromatography A 2006, 1129:145-148.
89. Swanson C.R., Joers V., Bondarenko V., Brunner K., Simmons H.A., Ziegler T.E., Kemnitz J.W., Johnson J.A., Emborg M.E. The PPAR-gamma agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys. Journal of Neuroinflammation 2011, 8:91.
90. Takeuch O., Akira S. Epigenetic control of macrophage polarization. European Journal of Immunology 2011, 41:2490-2493.
91. Takeuchi H., Yokota A., Ohoka Y., Kagechika H., Kato C., Song S.Y., Iwata M. Efficient induction of CCR9 on T cells requires coactivation of retinoic acid receptors and retinoid X receptors (RXRs): exaggerated T Cell homing to the intestine by RXR activation with organotins. Journal of Immunology 2010, 185:5289-5299.
92. Takeuchi T., Tsutsumi O. Serum bisphenol a concentrations showed gender differences, possibly linked to androgen levels. Biochemical and Biophysical Research Communications 2002, 291:76-78.
93. Teeguarden J.G., Calafat A.M., Ye X., Doerge D.R., Churchwell M.I., Gunawan R., Graham M.K. Twenty-four hour human urine and serum profiles of bisphenol A during high-dietary exposure. Toxicological Sciences 2011, 123:48-57.
94. Vandenberg L.N., Hauser R., Marcus M., Olea N., Welshons W.V. Human exposure to bisphenol A (BPA). Reproductive Toxicology 2007, 24:139-177.
95. Veldhoen M., Duarte J.H. The aryl hydrocarbon receptor: fine-tuning the immune-response. Current Opinion in Immunology 2010, 22:747-752.
96. Vucic E., Dickson S.D., Calcagno C., Rudd J.H., Moshier E., Hayashi K., Mounessa J.S., Roytman M., Moon M.J., Lin J., Tsimikas S., Fisher E.A., Nicolay K., Fuster V., Fayad Z.A. Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging. JACC. Cardiovascular Imaging 2011, 4:1100-1109.
97. Xu X., Dailey A.B., Talbott E.O., Ilacqua V.A., Kearney G., Asal N.R. Associations of serum concentrations of organochlorine pesticides with breast cancer and prostate cancer in U.S. adults. Environmental Health Perspectives 2010, 118:60-66.
98. Yamane H., Paul W.E. Memory CD4+ T cells: fate determination, positive feedback and plasticity. Cellular and Molecular Life Sciences (CMLS) 2012, 69:1577-1583.
99. Yamashita U., Sugiura T., Yoshida Y., Kuroda E. Effect of endocrine disrupters on thymocytes in vitro. Journal of UOEH 2003, 25:161-170.
100. Yan H., Takamoto M., Sugane K. Exposure to Bisphenol A prenatally or in adulthood promotes T(H)2 cytokine production associated with reduction of CD4CD25 regulatory T cells. Environmental Health Perspectives 2008, 116:514-519.
101. Yang Y., Lovett-Racke A.E., Racke M.K. Regulation of immune responses and autoimmune encephalomyelitis by PPARs. PPAR Research 2010, 104705.
102. Yeh C.H., Wu H.C., Kuo T.H., Kuo C.H., Yang S.N., Wang W.L., Chen H.N., Wei W.J., Hung C.H. Suppressive effect on MDC and IP-10 expression in monocytes by endocrine disruptor chemicals. Inflammation 2010, 33:10-17.
103. Yin D.Q., Hu S.Q., Gu Y., Wei L., Liu S.S., Zhang A.Q. Immunotoxicity of bisphenol A to Carassius auratus lymphocytes and macrophages following in vitro exposure. Journal of Environmental Science (China) 2007, 19:232-237.
104. Yoshino S., Yamaki K., Li X., Sai T., Yanagisawa R., Takano H., Taneda S., Hayashi H., Mori Y. Prenatal exposure to bisphenol A up-regulates immune responses, including T helper 1 and T helper 2 responses, in mice. Immunology 2004, 112:489-495.
105. Yoshino S., Yamaki K., Yanagisawa R., Takano H., Hayashi H., Mori Y. Effects of bisphenol A on antigen-specific antibody production, proliferative responses of lymphoid cells, and TH1 and TH2 immune responses in mice. British Journal of Pharmacology 2003, 138:1271-1276.
106. Yoshitake J., Kato K., Yoshioka D., Sueishi Y., Sawa T., Akaike T., Yoshimura T. Suppression of NO production and 8-nitroguanosine formation by phenol-containing endocrine-disrupting chemicals in LPS-stimulated macrophages: involvement of estrogen receptor-dependent or -independent pathways. Nitric Oxide: Biology and Chemistry/Official Journal of the Nitric Oxide Society 2008, 18:223-228.
107. Youn J.Y., Park H.Y., Lee J.W., Jung I.O., Choi K.H., Kim K., Cho K.H. Evaluation of the immune response following exposure of mice to bisphenol A: induction of Th1 cytokine and prolactin by BPA exposure in the mouse spleen cells. Archives of Pharmacal Research 2002, 25:946-953.
108. Yurino H., Ishikawa S., Sato T., Akadegawa K., Ito T., Ueha S., Inadera H., Matsushima K. Endocrine disruptors (environmental estrogens) enhance autoantibody production by B1 cells. Toxicological Sciences: An Official Journal of the Society of Toxicology 2004, 81:139-147.
109. Zha J., Wang Z. Acute and early life stage toxicity of industrial effluent on Japanese medaka (Oryzias latipes). The Science of the Total Environment 2006, 357:112-119.
110. Zhang J., Snyder S.H. Nitric oxide in the nervous system. Annual Review of Pharmacology and Toxicology 1995, 35:213-233.
111. Zoeller R.T., Bansal R., Parris C. Bisphenol-A, an environmental contaminant that acts as a thyroid hormone receptor antagonist in vitro, increases serum thyroxine, and alters RC3/neurogranin expression in the developing rat brain. Endocrinology 2005, 146:607-612.